CVS Health Co. (NYSE:CVS) Shares Sold by Venture Visionary Partners LLC

Venture Visionary Partners LLC lessened its stake in shares of CVS Health Co. (NYSE:CVS) by 1.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 14,330 shares of the pharmacy operator’s stock after selling 169 shares during the quarter. Venture Visionary Partners LLC’s holdings in CVS Health were worth $1,132,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Live Oak Investment Partners acquired a new position in shares of CVS Health during the fourth quarter valued at approximately $25,000. Atticus Wealth Management LLC increased its stake in shares of CVS Health by 149.0% during the fourth quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock valued at $29,000 after acquiring an additional 219 shares during the period. Cornerstone Planning Group LLC grew its position in CVS Health by 111.5% in the third quarter. Cornerstone Planning Group LLC now owns 461 shares of the pharmacy operator’s stock worth $32,000 after buying an additional 243 shares during the last quarter. PCA Investment Advisory Services Inc. acquired a new position in CVS Health in the second quarter worth approximately $37,000. Finally, ZRC Wealth Management LLC grew its position in CVS Health by 400.0% in the fourth quarter. ZRC Wealth Management LLC now owns 500 shares of the pharmacy operator’s stock worth $39,000 after buying an additional 400 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the stock. SVB Leerink assumed coverage on shares of CVS Health in a research report on Monday, February 26th. They issued an “outperform” rating and a $88.00 price target on the stock. Leerink Partnrs restated an “outperform” rating on shares of CVS Health in a research report on Monday, February 26th. Cantor Fitzgerald restated an “overweight” rating and issued a $87.00 price target on shares of CVS Health in a research report on Thursday. HSBC initiated coverage on shares of CVS Health in a research note on Friday, December 22nd. They issued a “buy” rating and a $94.00 price objective for the company. Finally, Piper Sandler raised their price objective on shares of CVS Health from $93.00 to $94.00 and gave the stock an “overweight” rating in a research note on Friday, March 15th. Four analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat.com, CVS Health presently has an average rating of “Moderate Buy” and a consensus price target of $89.44.

Insider Transactions at CVS Health

In other news, EVP Prem S. Shah sold 29,473 shares of the business’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the transaction, the executive vice president now owns 39,765 shares in the company, valued at approximately $3,059,916.75. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 0.25% of the company’s stock.

CVS Health Stock Performance

Shares of CVS opened at $74.58 on Friday. The company has a market capitalization of $93.86 billion, a PE ratio of 11.54, a price-to-earnings-growth ratio of 0.99 and a beta of 0.52. CVS Health Co. has a one year low of $64.41 and a one year high of $83.25. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.86 and a quick ratio of 0.63. The company’s fifty day moving average price is $76.08 and its 200 day moving average price is $73.76.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 EPS for the quarter, topping the consensus estimate of $2.01 by $0.11. The firm had revenue of $93.81 billion for the quarter, compared to the consensus estimate of $90.58 billion. CVS Health had a net margin of 2.33% and a return on equity of 15.25%. The business’s quarterly revenue was up 11.9% on a year-over-year basis. During the same quarter last year, the firm posted $1.99 EPS. As a group, analysts expect that CVS Health Co. will post 8.33 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd will be issued a dividend of $0.665 per share. The ex-dividend date is Friday, April 19th. This represents a $2.66 annualized dividend and a dividend yield of 3.57%. CVS Health’s payout ratio is 41.18%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.